Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In 2006, the research-and-development arm of Pliva was acquired by GlaxoSmithKline, which has ample resources for clinical trials, but the company has not commercialized the peptide
While many of the findings cited above were observed in animal studies (and therefore cannot be extrapolated to humans), there is evidence that researchers are actively exploring BCP-157s potential in these areas
Every vial of BPC-157 we ship is matched to a publicly accessible batch CoA, sealed in unbranded outer packaging, and lodged with Auspost Express the same business day from a domestic dispatch hub no customs hops, no relabelled batches, no anonymous resellers in the middle
The dubious promise of peptides as cure-all supersubstances can distract patients from the fundamentals of long-term care.
Proof is on the way
